Odypharm Limited

POWER SEARCH PRICING

SOLUTIONS

odypharm limited Company Information

Live

EstablishedMidDeclining

Company Number

05458659

Website

www.odypharm.org

Registered Address

1 princeton mews, 167-169 london road, kingston upon thames, surrey, KT2 6PT

Industry

Other business support service activities n.e.c.

Telephone

02089747252

Next Accounts Due

December 2024

Group Structure

View All

Directors

Santosh Deshpande13 Years

Gabriel Keita10 Years

View All

Shareholders

odypharm lifescience hong kong ltd 100%

odypharm limited Estimated Valuation

£8.4m

Pomanda estimates the enterprise value of ODYPHARM LIMITED at £8.4m based on a Turnover of £11.7m and 0.72x industry multiple (adjusted for size and gross margin).

Edit your figures and get a professional valuation report.

Odypharm Limited AI Business Plan

In just minutes, we combine Pomanda’s company and industry data with cutting edge Artificial Intelligence to build a comprehensive 27 section business plan. You then have 60 days to tailor the information, decide which sections to include or exclude, and add your own branding logos, images and color scheme to create your perfect plan.

View Sample

Odypharm Limited is a live company located in kingston upon thames, KT2 6PT with a Companies House number of 05458659. It operates in the other business support service activities n.e.c. sector, SIC Code 82990. Founded in May 2005, it's largest shareholder is odypharm lifescience hong kong ltd with a 100% stake. Odypharm Limited is a established, mid sized company, Pomanda has estimated its turnover at £11.7m with declining growth in recent years.

View Sample

Upgrade for unlimited company reports & a free credit check

Pomanda's financial health check has awarded Odypharm Limited a 3 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 6 areas for improvement. Company Health Check FAQs

Health Rating3out of 5

3 Strong

2 Regular

6 Weak

Size

annual sales of £11.7m, make it larger than the average company (£3m)

Growth

3 year (CAGR) sales growth of -9%, show it is growing at a slower rate (4.1%)

Very Low Risk70 - 100

Low Risk50 - 70

Moderate Risk30 - 50

High Risk20 - 30

Very High Risk0 - 20

Get a comprehensive credit check for odypharm limited. Get real-time insights into odypharm limited's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Perform a competitor analysis for odypharm limited by selecting its closest rivals and benchmarking them against 12 key performance metrics.

ODYPHARM LIMITED group structure

Odypharm Limited has no subsidiary companies.

Ultimate parent company

ODYPHARM LIFESCIENCE HONG KONG LTD

#0074256

1 parent

ODYPHARM LIMITED

05458659

ODYPHARM LIMITED Shareholders

odypharm lifescience hong kong ltd

100%

Odypharm Limited currently has 6 directors. The longest serving directors include Ms Santosh Deshpande (Sep 2010) and Mr Gabriel Keita (May 2014).

officer	country	age	start	end	role
Ms Santosh Deshpande	India	53 years	Sep 2010	-	Director
Mr Gabriel Keita	United Kingdom	57 years	May 2014	-	Director
Miss Liberty Davey	United Kingdom	32 years	Jun 2015	-	Director
Ms Liberty O'Brien	United Kingdom	32 years	Jun 2015	-	Director
Brice Meilo	United Kingdom	40 years	Jul 2015	-	Director
Mr Luc Meilo	United Kingdom	71 years	Oct 2015	-	Director

EXPORT

Odypharm Limited's latest turnover from March 2023 is estimated at £11.7 million and the company has net assets of £404.4 thousand. According to their latest financial statements, Odypharm Limited has 5 employees and maintains cash reserves of £653.3 thousand as reported in the balance sheet.

Data source: Companies House, Pomanda Estimates

	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	May 2013	May 2012	May 2011	May 2010
Turnover	11,689,318	11,492,967	10,342,372	15,587,809	9,021,988	4,687,392	3,641,101	3,962,919	6,457,513	4,912,360	2,468,362	302,093	462,082	480,414
Other Income Or Grants	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cost Of Sales	7,156,297	7,106,723	6,486,085	9,661,975	5,618,997	2,279,124	1,771,130	2,057,721	4,084,287	3,130,744	1,574,360	188,516	279,308	284,848
Gross Profit	4,533,021	4,386,244	3,856,286	5,925,833	3,402,991	2,408,268	1,869,971	1,905,198	2,373,226	1,781,615	894,002	113,577	182,774	195,566
Admin Expenses	5,174,207	3,470,044	4,960,075	5,617,124	3,545,638	1,963,000	1,795,389	1,565,891	2,197,845	1,784,442	584,713	82,166	35,939	92,517
Operating Profit	-641,186	916,200	-1,103,789	308,709	-142,647	445,268	74,582	339,307	175,381	-2,827	309,289	31,411	146,835	103,049
Interest Payable	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Interest Receivable	17,878	1,186	71	88	723	0	0	0	857	1,966	1,908	1,080	1,087	446
Pre-Tax Profit	-623,308	917,386	-1,103,718	308,796	-141,924	445,268	74,582	339,307	176,238	-861	311,197	32,491	147,922	103,494
Tax	0	-174,303	0	-58,671	0	-84,601	-14,736	-67,980	-37,010	0	-71,575	-7,798	-38,460	-28,978
Profit After Tax	-623,308	743,083	-1,103,718	250,125	-141,924	360,668	59,846	271,327	139,228	-861	239,622	24,693	109,462	74,516
Dividends Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Retained Profit	-623,308	743,083	-1,103,718	250,125	-141,924	360,668	59,846	271,327	139,228	-861	239,622	24,693	109,462	74,516
Employee Costs	218,688	207,940	200,023	198,168	191,811	181,399	177,719	178,589	1,815,488	1,375,425	696,623	110,239	143,904	142,245
Number Of Employees	5	5	5	5	5	5	5	5	51	39	19	3	4	4
EBITDA*	-604,267	938,757	-1,082,937	326,357	-114,012	459,831	105,900	356,845	181,903	-2,827	309,289	31,411	146,835	103,049

* Earnings Before Interest, Tax, Depreciation and Amortisation

	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	May 2013	May 2012	May 2011	May 2010
Tangible Assets	3,083	5,549	0	0	0	1,587	5,774	5,715	6,219	0	0	0	0	0
Intangible Assets	314,735	255,022	207,989	176,614	144,282	125,465	76,933	10,459	14,447	0	0	0	0	0
Investments & Other	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Debtors (Due After 1 year)	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Fixed Assets	317,819	260,572	207,989	176,614	144,282	127,053	82,708	16,174	20,666	0	0	0	0	0
Stock & work in progress	0	0	0	0	0	0	0	48,445	72,153	0	0	0	0	0
Trade Debtors	2,706,357	2,966,180	2,455,382	3,664,106	2,265,773	2,480,779	2,199,240	1,914,713	1,020,653	705,971	266,579	55,206	44,222	0
Group Debtors	0	0	0	0	73,953	16,742	41,594	328,878	0	0	0	0	0	0
Misc Debtors	123,341	76,499	37,254	49,689	129,376	87,666	115,069	128,768	0	0	0	0	0	0
Cash	653,279	188,049	128,159	13,704	162,046	30,638	63,649	198,815	144,054	198,872	587,689	175,577	256,533	178,199
misc current assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0
total current assets	3,482,978	3,230,729	2,620,795	3,727,499	2,631,149	2,615,826	2,419,553	2,619,619	1,236,859	904,843	854,268	230,783	300,755	178,199
total assets	3,800,797	3,491,301	2,828,784	3,904,113	2,775,431	2,742,879	2,502,260	2,635,793	1,257,526	904,843	854,268	230,783	300,755	178,199
Bank overdraft	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Bank loan	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Trade Creditors	737,516	468,624	433,312	967,551	453,185	712,740	839,020	741,968	656,428	442,756	390,755	6,892	101,557	88,463
Group/Directors Accounts	2,252,133	1,577,163	1,765,092	1,139,710	871,993	564,650	661,049	325,803	0	0	0	0	0	0
other short term finances	0	0	0	0	0	0	0	0	0	0	0	0	0	0
hp & lease commitments	0	0	0	0	0	0	0	0	0	0	0	0	0	0
other current liabilities	406,736	417,795	345,440	408,367	312,006	185,317	40,315	675,276	0	0	0	0	0	0
total current liabilities	3,396,386	2,463,582	2,543,845	2,515,628	1,637,185	1,462,708	1,540,385	1,743,048	656,428	442,756	390,755	6,892	101,557	88,463
loans	0	0	0	0	0	0	0	0	0	0	0	0	0	0
hp & lease commitments	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Accruals and Deferred Income	0	0	0	0	0	0	0	0	0	0	0	0	0	0
other liabilities	0	0	0	0	0	0	0	0	0	1,395	1,450	1,450	1,450	1,450
provisions	0	0	0	0	0	0	0	0	0	0	0	0	0	0
total long term liabilities	0	0	0	0	0	0	0	0	0	1,396	1,450	1,450	1,450	1,450
total liabilities	3,396,386	2,463,582	2,543,845	2,515,628	1,637,185	1,462,708	1,540,385	1,743,048	656,428	444,152	392,205	8,342	103,007	89,913
net assets	404,411	1,027,719	284,939	1,388,485	1,138,246	1,280,171	961,876	892,745	601,098	460,690	462,063	222,441	197,748	88,286
total shareholders funds	404,411	1,027,719	284,939	1,388,485	1,138,246	1,280,171	961,876	892,745	601,098	460,690	462,063	222,441	197,748	88,286

	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	May 2013	May 2012	May 2011	May 2010
Operating Activities
Operating Profit	-641,186	916,200	-1,103,789	308,709	-142,647	445,268	74,582	339,307	175,381	-2,827	309,289	31,411	146,835	103,049
Depreciation	2,466	1,850	0	0	1,586	3,934	15,660	1,797	250	0	0	0	0	0
Amortisation	34,453	20,707	20,852	17,648	27,048	10,629	15,658	15,741	6,272	0	0	0	0	0
Tax	0	-174,303	0	-58,671	0	-84,601	-14,736	-67,980	-37,010	0	-71,575	-7,798	-38,460	-28,978
Stock	0	0	0	0	0	0	-48,445	-23,708	72,153	0	0	0	0	0
Debtors	-212,982	550,044	-1,221,159	1,244,692	-116,084	229,284	-16,457	1,351,707	314,683	439,391	211,373	10,984	44,222	0
Creditors	268,892	35,312	-534,239	514,366	-259,555	-126,280	97,052	85,540	213,671	52,001	383,863	-94,665	13,094	88,463
Accruals and Deferred Income	-11,059	72,355	-62,927	96,361	126,689	145,002	-634,961	675,276	0	0	0	0	0	0
Deferred Taxes & Provisions	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cash flow from operations	-133,452	322,077	-458,944	-366,279	-130,795	164,668	-381,843	-278,318	-28,272	-390,217	410,204	-82,036	77,247	162,534
Investing Activities
capital expenditure	-94,166	-75,139	-52,227	-49,980	-45,864	-58,908	-97,851	-13,046	-27,188	0	0	0	0	0
Change in Investments	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash flow from investments	-94,166	-75,139	-52,227	-49,980	-45,864	-58,908	-97,851	-13,046	-27,188	0	0	0	0	0
Financing Activities
Bank loans	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Group/Directors Accounts	674,970	-187,929	625,382	267,716	307,343	-96,399	335,246	325,803	0	0	0	0	0	0
Other Short Term Loans	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Long term loans	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Hire Purchase and Lease Commitments	0	0	0	0	0	0	0	0	0	0	0	0	0	0
other long term liabilities	0	0	0	0	0	0	0	0	-1,395	-55	0	0	0	1,450
share issue	0	-304	172	113	0	-42,373	9,284	20,321	1,179	-512	0	0	0	13,770
interest	17,878	1,186	71	88	723	0	0	0	857	1,966	1,908	1,080	1,087	446
cash flow from financing	692,848	-187,047	625,625	267,917	308,066	-138,772	344,530	346,124	641	1,399	1,908	1,080	1,087	15,666
cash and cash equivalents
cash	465,230	59,890	114,455	-148,342	131,407	-33,010	-135,166	54,761	-54,818	-388,817	412,112	-80,956	78,334	178,199
overdraft	0	0	0	0	0	0	0	0	0	0	0	0	0	0
change in cash	465,230	59,890	114,455	-148,342	131,407	-33,010	-135,166	54,761	-54,818	-388,817	412,112	-80,956	78,334	178,199

P&L

March 2023

turnover

11.7m

+2%

operating profit

-641.2k

gross margin

38.8%

+1.61%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

March 2023

net assets

404.4k

-0.61%

total assets

3.8m

+0.09%

cash

653.3k

+2.47%

net assets

Total assets minus all liabilities

Similar Companies

Agree?

diaros trading limited

ifse group limited

information security forum limited

4.5

hull esteem consortium psp limited

pentland brands limited

3.5

company number

05458659

Type

Private limited with Share Capital

industry

82990 - Other business support service activities n.e.c.

incorporation date

May 2005

age

accounts

Small Company

ultimate parent company

ODYPHARM LIFESCIENCE HONG KONG LTD

previous names

N/A

incorporated

address

1 princeton mews, 167-169 london road, kingston upon thames, surrey, KT2 6PT

last accounts submitted

March 2023

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We did not find charges/mortgages relating to odypharm limited.

odypharm limited Company Information

odypharm limited Estimated Valuation

odypharm limited Estimated Valuation

odypharm limited Estimated Valuation

Odypharm Limited AI Business Plan

Odypharm Limited Overview

Odypharm Limited Health Check

odypharm limited Credit Report and Business Information

Odypharm Limited Competitor Analysis

odypharm limited Ownership

odypharm limited directors

ODYPHARM LIMITED financials

odypharm limited company details

odypharm limited Charges & Mortgages

odypharm limited Companies House Filings - See Documents